XCEL BRANDS INC (XELB)

US98400M1018 - Common Stock

0.3321  -0.01 (-2.32%)

After market: 0.3316 0 (-0.15%)

Fundamental Rating

2

Overall XELB gets a fundamental rating of 2 out of 10. We evaluated XELB against 121 industry peers in the Specialty Retail industry. Both the profitability and financial health of XELB have multiple concerns. XELB has a valuation in line with the averages, but on the other hand it scores bad on growth.



1

1. Profitability

1.1 Basic Checks

XELB had negative earnings in the past year.
XELB had a negative operating cash flow in the past year.
In the past 5 years XELB always reported negative net income.
In multiple years XELB reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -28.55%, XELB is doing worse than 88.33% of the companies in the same industry.
XELB has a Return On Equity of -39.19%. This is in the lower half of the industry: XELB underperforms 68.33% of its industry peers.
Industry RankSector Rank
ROA -28.55%
ROE -39.19%
ROIC N/A
ROA(3y)-14.53%
ROA(5y)-11.3%
ROE(3y)-21.38%
ROE(5y)-16.55%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 95.35%, XELB belongs to the top of the industry, outperforming 99.17% of the companies in the same industry.
XELB's Gross Margin has declined in the last couple of years.
XELB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 95.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.17%
GM growth 5Y-7.95%

1

2. Health

2.1 Basic Checks

XELB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for XELB has been increased compared to 1 year ago.
Compared to 5 years ago, XELB has more shares outstanding
Compared to 1 year ago, XELB has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -1.71, we must say that XELB is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.71, XELB is doing worse than 85.00% of the companies in the same industry.
XELB has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.08, XELB is in the better half of the industry, outperforming 70.83% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z -1.71
ROIC/WACCN/A
WACC9.26%

2.3 Liquidity

XELB has a Current Ratio of 0.79. This is a bad value and indicates that XELB is not financially healthy enough and could expect problems in meeting its short term obligations.
XELB has a worse Current ratio (0.79) than 88.33% of its industry peers.
A Quick Ratio of 0.72 indicates that XELB may have some problems paying its short term obligations.
XELB's Quick ratio of 0.72 is fine compared to the rest of the industry. XELB outperforms 63.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.72

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 35.53% over the past year.
Looking at the last year, XELB shows a very negative growth in Revenue. The Revenue has decreased by -52.97% in the last year.
The Revenue for XELB have been decreasing by -12.93% on average. This is quite bad
EPS 1Y (TTM)35.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.89%
Revenue 1Y (TTM)-52.97%
Revenue growth 3Y-15.52%
Revenue growth 5Y-12.93%
Sales Q2Q%-56.44%

3.2 Future

XELB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 46.78% yearly.
The Revenue is expected to grow by 0.38% on average over the next years.
EPS Next Y59.82%
EPS Next 2Y46.78%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-44.93%
Revenue Next 2Y0.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

4

4. Valuation

4.1 Price/Earnings Ratio

XELB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 3.26, which indicates a rather cheap valuation of XELB.
Based on the Price/Forward Earnings ratio, XELB is valued cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of XELB to the average of the S&P500 Index (23.99), we can say XELB is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 3.26

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XELB's earnings are expected to grow with 46.78% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.78%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for XELB!.
Industry RankSector Rank
Dividend Yield N/A

XCEL BRANDS INC

NASDAQ:XELB (12/24/2024, 7:46:32 PM)

After market: 0.3316 0 (-0.15%)

0.3321

-0.01 (-2.32%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)12-23 2024-12-23/amc
Earnings (Next)N/A N/A
Inst Owners26.91%
Inst Owner Change-1.43%
Ins Owners41.15%
Ins Owner Change0%
Market Cap7.83M
Analysts82.86
Price Target2.04 (514.27%)
Short Float %0.65%
Short Ratio3.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)69.36%
Min EPS beat(2)50.98%
Max EPS beat(2)87.75%
EPS beat(4)4
Avg EPS beat(4)47.01%
Min EPS beat(4)5.88%
Max EPS beat(4)87.75%
EPS beat(8)6
Avg EPS beat(8)21.47%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.13%
Min Revenue beat(2)-11.64%
Max Revenue beat(2)-2.63%
Revenue beat(4)0
Avg Revenue beat(4)-6.33%
Min Revenue beat(4)-11.64%
Max Revenue beat(4)-2.01%
Revenue beat(8)2
Avg Revenue beat(8)-0.04%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.26
P/S 0.78
P/FCF N/A
P/OCF N/A
P/B 0.17
P/tB 0.83
EV/EBITDA N/A
EPS(TTM)-0.49
EYN/A
EPS(NY)0.1
Fwd EY30.71%
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS0.43
BVpS1.95
TBVpS0.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -28.55%
ROE -39.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 95.35%
FCFM N/A
ROA(3y)-14.53%
ROA(5y)-11.3%
ROE(3y)-21.38%
ROE(5y)-16.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.17%
GM growth 5Y-7.95%
F-Score2
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.91%
Cap/Sales 1.23%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.72
Altman-Z -1.71
F-Score2
WACC9.26%
ROIC/WACCN/A
Cap/Depr(3y)7.23%
Cap/Depr(5y)58.14%
Cap/Sales(3y)1.53%
Cap/Sales(5y)6.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.89%
EPS Next Y59.82%
EPS Next 2Y46.78%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-52.97%
Revenue growth 3Y-15.52%
Revenue growth 5Y-12.93%
Sales Q2Q%-56.44%
Revenue Next Year-44.93%
Revenue Next 2Y0.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year87.56%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y19.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.58%
OCF growth 3YN/A
OCF growth 5YN/A